1. Morgan DR, Benshoff M, Cáceres M, et al. Irritable bowel syndrome and gastrointestinal parasite infection in a developing nation environment. Gastroenterol Res Pract. 2012; 2012:343812. PMID:
22474433.
Article
2. Pokkunuri V, Pimentel M, Morales W, et al. Role of cytolethal distending toxin in altered stool form and bowel phenotypes in a rat model of post-infectious irritable bowel syndrome. J Neurogastroenterol Motil. 2012; 18:434–442. PMID:
23106005.
Article
3. Thabane M, Kottachchi DT, Marshall JK. Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther. 2007; 26:535–544. PMID:
17661757.
Article
4. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006; 130:1480–1491. PMID:
16678561.
Article
5. Spiller R, Lam C. An update on post-infectious irritable bowel syndrome: role of genetics, immune activation, serotonin and altered microbiome. J Neurogastroenterol Motil. 2012; 18:258–268. PMID:
22837873.
Article
6. Swarbrick ET, Hegarty JE, Bat L, Williams CB, Dawson AM. Site of pain from the irritable bowel. Lancet. 1980; 2:443–446. PMID:
6106097.
Article
7. Whorwell PJ, McCallum M, Creed FH, Roberts CT. Non-colonic features of irritable bowel syndrome. Gut. 1986; 27:37–40. PMID:
3949235.
Article
8. Hershfield NB. Nongastrointestinal symptoms of irritable bowel syndrome: an office-based clinical survey. Can J Gastroenterol. 2005; 19:231–234. PMID:
15861265.
Article
9. De Giorgio R, Barbara G, Stanghellini V, et al. Diagnosis and therapy of irritable bowel syndrome. Aliment Pharmacol Ther. 2004; 20(Suppl 2):10–22. PMID:
15335409.
Article
10. Jellema P, van der Windt DA, Schellevis FG, van der Horst HE. Systematic review: accuracy of symptom-based criteria for diagnosis of irritable bowel syndrome in primary care. Aliment Pharmacol Ther. 2009; 30:695–706. PMID:
19575763.
Article
11. Ramirez-Miranda ME, Hernandez-Castellanos R, Lopez-Escamilla E, et al. Parasites in Mexican patients with irritable bowel syndrome: a case-control study. Parasit Vectors. 2010; 3:96. PMID:
20942938.
Article
12. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006; 130:1377–1390. PMID:
16678553.
Article
13. Vanner SJ, Depew WT, Paterson WG, et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol. 1999; 94:2912–2917. PMID:
10520844.
Article
14. Cash BD, Chey WD. Irritable bowel syndrome: an evidence-based approach to diagnosis. Aliment Pharmacol Ther. 2004; 19:1235–1245. PMID:
15191504.
15. de Silva NR, Brooker S, Hotez PJ, Montresor A, Engels D, Savioli L. Soil-transmitted helminth infections: updating the global picture. Trends Parasitol. 2003; 19:547–551. PMID:
14642761.
Article
16. Haas W, Haberl B, Syafruddin , et al. Behavioural strategies used by the hookworms Necator americanus and Ancylostoma duodenale to find, recognize and invade the human host. Parasitol Res. 2005; 95:30–39. PMID:
15614587.
Article
17. Hotez PJ, Brooker S, Bethony JM, Bottazzi ME, Loukas A, Xiao S. Hookworm infection. N Engl J Med. 2004; 351:799–807. PMID:
15317893.
Article
18. Gilles HM. Selective primary health care: strategies for control of disease in the developing world. XVII. Hookworm infection and anemia. Rev Infect Dis. 1985; 7:111–118. PMID:
3983524.
Article
19. Shale M, Travis SP. Exposure to hookworms in patients with Crohn's disease. Aliment Pharmacol Ther. 2011; 34:1248–1249. PMID:
22004256.
Article